Atlas Trials

A Study of Toripalimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma.

Clinical trial NCT04084158 · SUSPENDED

Trial details

NCT number
NCT04084158
Sponsor
Zhejiang Cancer Hospital
Status
SUSPENDED
Phase
Phase 2
Study type
INTERVENTIONAL
Esophageal Squamous Cell Carcinoma
Start date
2019-09-07
Primary completion
2021-12-30
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.